Powder: -20°C for 3 years | In solvent: -80°C for 2 years
MK-3328 has a high affinity for β-Amyloid (IC50:10.5 nM), and can be used as a candidate PET ligand for clinical assessment of β-amyloid plaque load. MK-3328 is a potential treatment for Alzheimer's disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 350.00 | |
5 mg | In stock | $ 828.00 | |
10 mg | In stock | $ 1,130.00 | |
25 mg | In stock | $ 1,590.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,500.00 | |
500 mg | In stock | $ 4,900.00 |
Description | MK-3328 has a high affinity for β-Amyloid (IC50:10.5 nM), and can be used as a candidate PET ligand for clinical assessment of β-amyloid plaque load. MK-3328 is a potential treatment for Alzheimer's disease. |
Targets&IC50 | β-Amyloid:10.5 nM |
In vitro | MK-3328 displays amyloid binding potency balanced with low levels of nonspecific binding.[1] |
In vivo | In normal rhesus monkey positron emission tomography (PET) imaging studies, [18F]MK-3328 demonstrates favorable kinetics, exhibiting high brain uptake, and good washout.[2] |
Molecular Weight | 268.25 |
Formula | C14H9FN4O |
CAS No. | 1201323-97-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
DMSO: <10mM
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MK-3328 1201323-97-8 Others MK3328 MK 3328 inhibitor inhibit